BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2458715)

  • 1. The relationship between inhibition of plasminogen-activator activity and prostatic involution.
    Rennie PS; Bowden JF; Bruchovsky N; Cheng H
    Biochem J; 1988 Jun; 252(3):759-64. PubMed ID: 2458715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activity of plasminogen activators during involution of the rat ventral prostate.
    Rennie PS; Bouffard R; Bruchovsky N; Cheng H
    Biochem J; 1984 Jul; 221(1):171-8. PubMed ID: 6431969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats.
    Freeman SN; Rennie PS; Chao J; Lund LR; Andreasen PA
    Biochem J; 1990 Jul; 269(1):189-93. PubMed ID: 2115769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of omega-aminoacids and clot formation on the activation by urokinase of various plasminogen preparations.
    Takada A; Takada Y
    Thromb Res; 1980 Apr 1-15; 18(1-2):167-76. PubMed ID: 6773180
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of plasminogen activator in ovulation.
    Akazawa K; Matsuo O; Kosugi T; Mihara H; Mori N
    Acta Physiol Lat Am; 1983; 33(2):105-10. PubMed ID: 6422700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis.
    Brosnan CF; Cammer W; Norton WT; Bloom BR
    Nature; 1980 May; 285(5762):235-7. PubMed ID: 6154893
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of antifibrinolytic agents on wound healing.
    Björlin G; Nilsson IM
    Int J Oral Maxillofac Surg; 1988 Aug; 17(4):275-6. PubMed ID: 3139802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of saruplase with acetylsalicylic acid, heparin, glyceryl trinitrate, tranexamic acid and aprotinin in a rabbit pulmonary thrombosis model.
    Schneider J
    Arzneimittelforschung; 1990 Oct; 40(10):1180-4. PubMed ID: 1705427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol alters gene expression during involution of the rat ventral prostate.
    Rennie PS; Bowden JF; Freeman SN; Bruchovsky N; Cheng H; Lubahn DB; Wilson EM; French FS; Main L
    Mol Endocrinol; 1989 Apr; 3(4):703-8. PubMed ID: 2498651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence polarization and spectropolarimetric studies on the conformational changes induced by omega-aminoacids in two isozymes of Glu-plasminogen (I and II).
    Sugawara Y; Takada Y; Takada A
    Thromb Res; 1984 Feb; 33(3):269-75. PubMed ID: 6710433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE; Lundén R; Wallén P
    Haemostasis; 1982; 11(4):235-41. PubMed ID: 6982199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence spectrophotometric studies on the conformational changes induced by omega-aminoacids in two isozymes of Glu-plasminogen (I and II).
    Takada A; Takada Y; Sugawara Y
    Thromb Res; 1984 Mar; 33(5):461-9. PubMed ID: 6719394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of inhibitors of fibrinolysis.
    Verstraete M
    Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification and some properties of the tissue plasminogen activator from the human myometrium.
    Soszka T
    Thromb Res; 1977 Jun; 10(6):823-32. PubMed ID: 18814
    [No Abstract]   [Full Text] [Related]  

  • 19. The in vitro activation of complement by radiologic contrast materials and its inhibition with epsilon-aminocaproic acid.
    Neoh SH; Sage MR; Willis RB; Roberts-Thomson P; Bradley J
    Invest Radiol; 1981; 16(2):152-8. PubMed ID: 6783593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the effects of tranexamic acid and its isobenzedrine ester on plasminogen activation and streptokinase induced fibrinolysis.
    Baldacci M; Catalani R; Bartoli C; Del Corso A; Tozzi MG; Mura U
    Boll Soc Ital Biol Sper; 1989 Jun; 65(6):521-8. PubMed ID: 2611013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.